30th International Conference on Molecular Medicine


6-8 November 2025


Four Points by Sheraton Catania


Catania, Italy





Presentations Include:


The list is incomplete and will be updated periodically:



  • Russ Reiter - (USA) - Dual sources of melatonin and evidence of different primary functions.
  •  
  • Adel El-Naggar - (USA) - Premalignant Head and Neck squamous epithelium: Regional and biological heterogeneity.
  •  
  • Wei Zhu - (USA) - Investigating the Neuroprotective Effects of Conjugated Linoleic Acid Against Potassium Bromate-Induced Damage.
  •    
  • Daniel Gomez – (Argentina) – Improving therapeutic strategies for triple-negative breast cancer: synergistic effects of DKC1 inhibition and paclitaxel
  •    
  • Emmanouil Karteris - (UK) - Clinical utility of liquid biopsies as diagnostic or prognostic cancer biomarkers.
  •  
  • Sandra Marmiroli - (Italy) - CAPTURE-Capivasertib and Prostate Cancer Targeting: Unraveling Resistance Elements.
  •  
  • Ayodele Alaiya - (Saudi Arabia) - Predictive Biomarkers of COVID-19 Outcomes in Immunosuppressed Renal Transplant Recipients.
  •  
  • Demetrios Spandidos - (Greece) - The cancer story and publishing in biomedical sciences.
  •  
  • Paola Poma - (Italy) - Hallmarks of acquired multi-drug resistance in cancer cells: overcoming it.
  •  
  • Stefania Stella - (Italy) - Different BCR::ABL1 Transcript Levels @ 3 and 6 Months Might Be Useful In Identifying Warning/Resistant CML Patients When Using 2G-TKIS As Frontline Treatment.
  •    
  • Filomena de Nigris - (Italy) - YY1 and PCGa copperatively regulate mitochondrial gene transcription in X9-11 translocated Renal Carcinoma.
  •  
  • Saif ur Rehman - (China) - Proteomics evaluation of villi cell
  •  
  • Irina Groisman - (France) - Pro-tumorigenic role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in prostate cancer.
  •  
  • Joo Young Kim - (South Korea) - Metformin increases apoptotic sensitivity of cisplatin in Caki cells.
  •  
  • Maria Zervou - (Greece) - Where there is endometriosis, an autoimmune disease may co-occur: Genetic aspects for the cases of SLE, PS, PsA and APS
  •  
  • Iordanis Mourouzis - (Greece) - Cilostazol promotes myogenesis and protects microvascular endothelial cells under diabetic conditions in vitro: therapeutic implications for diabetes
  •  
  • Gian Marco Leone - (Italy) - New Horizons in Oncology: The Identification of Promising Therapeutic Targets
  •  
  • Beate Köberle - (Germany) - RNA is a pro-apoptotic target of cisplatin in cancer cells
  •  
  • Walburgis Brenner - (Germany) - Influence of components of the follicular fluid on endometriosis
  •  
  • Karla Aguirre - (Mexico) - Antitumor Effect of Orally Administered Aqueous Extract of Riñonina (Ipomoea pes-caprae), Alone and in Comparison with Cisplatin, on an In Vivo Model of Triple-Negative Breast Cancer (MDA-MB-231)
  •  
  • Maitham Khajah - (Kuwait) - Lactate is a major promotor of breast cancer cell aggressiveness
  •  
  • Izabela Zawlik - (Poland) - Abnormalities of GAS5, PTEN and miR-21 expression in endometrial cancer
  •  
  • Muhammad Ajmal - (Pakistan) - Development of anticancer drugs for target specific delivery to pediatric brin tumour
  •  
  • Jérémy Laurent - (France) - Evaluation of a new administration route for tricyclo-DNA antisense oligonucleotides for the systemic treatment of neuromuscular diseases
  •    
  • Rebaz Mustafa - (Iraq) - Investigating the Role of A3H in Breast Ductal Carcinoma and its Association with miRNA-103a-2-5p.
  •    
  • Tomoki Sengiku - (Japan) - Pre-treatment serum CEA as a Novel Biomarker for Recurrence in Intermediate- and High-Risk Stage IB–IIB Cervical Cancer Treated with Radical Hysterectomy Followed by TP Chemotherapy as adjuvant chemotherapy.
  •    
  • Kyosuke Yasuda - (Japan) - Pembrolizumab/Lenvatinib Combination Therapy for Uterine Corpus Cancer: A Single-Center, Retrospective Analysis.
  •    
  • Minato Tagawa - (Japan) - Exceptional response to pembrolizumab in chemotherapy-resistant recurrent ovarian cancer patient with TMB-High : a case report.
  •    
  • Giuseppe Broggi - (Italy) - Evaluation of CDKN2A/B homozygous deletion in Central Nervous System tumors.
  •  
  • Vincenzo Fiorentino - (Italy) - A morphological signature of Megakaryocytic Activation (M-ACT) for predicting myelofibrotic evolution in Philadelphia-Negative Myeloproliferative Neoplasms
  •  
  • Valeria Zuccalà - (Italy) - Integrated immunogenomic profiling of triple-negative breast cancer reveals distinct prognostic subtypes
  •  
  • Ludovica Pepe - (Italy) - Prognostic significance of the AR, ADAR2, and PD-L1 axis in papillary urothelial carcinoma
  •  
  • Cristina Pizzimenti - (Italy) - Prognostic evaluation of morphological, immunophenotypic and radiological markers in primary central nervous system diffuse large B-cell lymphomas
  •  
  • Maria Sofia Basile - (Italy) - In silico analysis of the cerebellar transcriptomic profile in Alzheimer's disease patients and identification of novel potential therapeutic strategies
  •  
  • Chiara Capasso - (Italy) - Caulerpin as a preventive antitumor and anti-inflammatory agent in sporadic and FAP colorectal cancer
  •  
  • Valeria D'Agostino - (Italy) - Hamartomatous polyposis syndromes: role of succinate dehydrogenase (SDH) in STK11 gene regulation
  •  
  • Tony D'Agostino - (Italy) - Stemness Targeted Therapies to Overcome Endocrine Resistance in ER+ Breast Cancer.
  •  
  • Lucia Altucci - (Italy) - Targeting epigenome in cancer.
  •  
  • Reyhaneh Farghadani - (Malaysia) - From turmeric to therapy: how curcumin, a molecular powerhouse, is restoring apoptosis in breast cancer treatment.
  •    
  • Alessandro Lavoro – (Italy) - Targeting of DNA methylation induces MMP-9/NGAL overexpression and increased immune cell infiltration in melanoma
  •  
  • Federica Longo - (Italy) - Identification of microRNAs as potential Therapeutic Targets in Drug-Resistant Colorectal Cancer
  •  
  • Anastasia Vitale – (Italy) - c-Kit- and NF1-mutated GISTs: molecular features and therapeutic opportunities
  •  
  • Graziana Spoto – (Italy) - Insights into Colorectal Cancer Drug Resistance: from Genomic to Transcriptomic Signatures
  •  
  • Concettina Fenga (Italy), Denis Vinnikov – (Kazakhstan) - Venerando Rapisarda (Italy)
  •  
  • Veronica Filetti – (Italy) – Small RNA-Seq Transcriptome Profiling of Mesothelial and Mesothelioma Cell Lines Revealed microRNA Dysregulation after Exposure to Asbestos-like Fibers
  •  
  • Federica Giambò – (Italy) – Heavy Metals: Toxicity and Renal Damage
  •  
  • Serena Matera – (Italy) – Obesity as a risk factor for worker health: evaluation of inflammatory markers in a population of healthcare workers
  •  
  • Caterina Oliveri – (Italy) – Occupational toxicants exposure in the workplace and its effect on the immune system of shift workers
  •  
  • Paola Senia – (Italy) – Arsenic exposure and expression of inflammation-regulating cytokines: a study of a cohort of construction workers
  •  
  • Giuseppe Sferrazzo – (Italy) – Analysis of ROS and cytokine production in workers exposed to nickel dust inhalation
  •  
  • Michele Teodoro – (Italy) – Melanoma and UV Exposure: Understanding Mutation-Driven Oncogenesis
  •  
  • Francesca Vella – (Italy) – Oxidative stress and DNA damage in pesticide-exposed greenhouse workers
  •  
  • Silvia Vivarelli – (Italy) – Exploring the Role of YY1 in Clock Genes Regulation and Breast Cancer in Night Shift Workers
  •  
  • Ermanno Vitale – (Italy) – miRNA expression levels in workers exposed to asbestiform fibers: comparison of subjects exposed to Metsovo (tremolite) with those of Biancavilla (fluoro-edenite)
  •  





    Back to Top